William Grossman's most recent trade in Day One Biopharmaceuticals Inc was a trade of 66,660 Stock Option (right to buy Common Stock) done . Disclosure was reported to the exchange on Nov. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 66,660 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 32,335 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| enGene Holdings Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Grossman William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.68 per share. | 16 Jun 2021 | 3,891 | 20,723 (0%) | 0% | 23.7 | 92,139 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.13 per share. | 16 Jun 2021 | 3,047 | 24,741 (0%) | 0% | 24.1 | 73,524 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.77 per share. | 16 Jun 2021 | 127 | 24,614 (0%) | 0% | 24.8 | 3,146 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.37 per share. | 23 Apr 2021 | 4,133 | 6,717 (0%) | 0% | 31.4 | 129,652 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 16 Mar 2021 | 2,127 | 10,850 (0%) | 0% | 35.0 | 74,509 | Common Stock |